Search results for "Psychotic disorder"

showing 10 items of 173 documents

Substance use, medication adherence and outcome one year following a first episode of psychosis

2016

Both substance use and poor medication adherence are associated with poor outcome in psychosis. To clarify the contributions of substance use and poor medication adherence to poor outcome in the year following a first episode of psychosis, 205 patients were evaluated for use of tobacco, alcohol, cannabis and stimulants at their psychosis onset, and in a 1-year follow-up. Data on medication adherence and symptom remission were also collected. Patients had high rates of overall substance use before (37-65%) and after psychosis onset (45-66%). 44% showed poor medication adherence and 55% did not reach remission from psychosis. Nicotine dependence and cannabis use after psychosis onset signific…

Nicotine dependenceAdultMalePsychosismedicine.medical_specialtyFirst episode psychosisRemissionSubstance-Related DisordersMedication adherenceSubstance useCannabis useMedication AdherenceCannabis use; First episode psychosis; Medication adherence; Nicotine dependence; Remission; Substance use; Acute Disease03 medical and health sciencesYoung Adult0302 clinical medicineSettore M-PSI/08 - Psicologia ClinicamedicineHumansYoung adultCannabis use; First episode psychosis; Medication adherence; Nicotine dependence; Remission; Substance use; Acute Disease; Adult; Antipsychotic Agents; Female; Follow-Up Studies; Humans; Male; Medication Adherence; Middle Aged; Psychotic Disorders; Substance-Related Disorders; Treatment Outcome; Young AdultNicotine dependencePsychiatryMedication adherenceSettore MED/25 - PsichiatriaBiological PsychiatryFirst episodebiologyCannabis useMiddle Agedmedicine.diseasebiology.organism_classificationFirst episode psychosi030227 psychiatryTreatment OutcomePsychotic DisordersPsychiatry and Mental HealthAcute DiseaseFemaleCannabisSubstance usePsychology030217 neurology & neurosurgeryAntipsychotic AgentsFollow-Up Studies
researchProduct

The usefulness of Olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosis

2021

Introduction: The role of Olanzapine therapeutic drug monitoring is controversial. The present study explores the associations of Olanzapine plasma concentrations with clinical response and metabolic side effects in first episode psychosis (FEP) after 2 months of treatment. Methods: Forty-seven patients were included. Improvement in clinical symptomatology was assessed using the PANSS. Metabolic assessment included weight, blood pressure, waist circumference, blood glucose, total cholesterol, high-density lipoprotein, low-density lipoprotein, and triglycerides. Results: The Olanzapine plasma concentrations after 2 months of treatment were positively correlated with weight gain (r = 0.49, p …

OlanzapineAdultBlood GlucoseMalemedicine.medical_specialtyFarmacologiaWaistBlood PressureWeight GainGastroenterology03 medical and health sciences0302 clinical medicinePharmacokineticsInternal medicinemedicineHumansPharmacologyValproic Acidmedicine.diagnostic_testbusiness.industrySmokingMiddle Aged030227 psychiatryBlood pressureTreatment OutcomePsychotic DisordersTherapeutic drug monitoringOlanzapineFemalemedicine.symptomDrug MonitoringbusinessWeight gain030217 neurology & neurosurgeryMedicamentsLipoproteinmedicine.drugAntipsychotic Agents
researchProduct

Course of weight gain and metabolic abnormalities in first treated episode of psychosis: the first year is a critical period for development of cardi…

2014

Data on the long-term metabolic side-effects associated with antipsychotics are scarce. Prospective longitudinal studies in medication-naive patients with a first episode of psychosis are a valuable source of information as they provide an assessment prior to the antipsychotic exposure and minimize the effect of potential confounding factors. The aim of this study was to assess the course of weight gain and the incidence of metabolic abnormalities during the first 3 yr of antipsychotic treatment. Data were collected from a cohort of 170 first-episode psychosis patients. They were randomly assigned to haloperidol (32%); olanzapine (32%) and risperidone (36%). The dose used was flexible. The …

OlanzapineAdultMaleMedication-naivemedicine.medical_specialtyTime FactorsAdolescentmedicine.medical_treatmentWeight GainBenzodiazepinesYoung AdultMetabolic DiseasesRisk FactorsMetabolic side effectsInternal medicinemedicineHumansAntipsychoticsPharmacology (medical)Prospective StudiesAntipsychoticPsychiatryProspective cohort studyPharmacologyFirst episodeRisperidoneMiddle AgedRisperidoneFirst-episode psychosisCardiovascular riskCritical periodPsychiatry and Mental healthTolerabilityPsychotic DisordersOlanzapineCohortHaloperidolmedicine.symptomPsychologyWeight gainmedicine.drugAntipsychotic Agents
researchProduct

Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review

2017

Marco Solmi,1,2 Andrea Murru,3 Isabella Pacchiarotti,3 Juan Undurraga,4,5 Nicola Veronese,2,6 Michele Fornaro,7,8 Brendon Stubbs,2,9–11 Francesco Monaco,2 Eduard Vieta,3 Mary V Seeman,12 Christoph U Correll,13,14 André F Carvalho2,15 1Neuroscience Department, University of Padua, 2Institute for Clinical Research and Education in Medicine, Padua, Italy; 3Bipolar Disorders Unit, Institute of Neuroscience, Hospital Clínic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain; 4Department of Psychiatry, Faculty of Medicine, Clínica Alemana Universidad del Desarrollo, 5Early Intervention Program, J. Horwitz Psychiatric Institute, Santiago, Chile; 6Na…

Olanzapinesafetymedicine.medical_specialtyside effectToxicology and Pharmaceutics (all)ReviewRM1-950psychosi03 medical and health sciencesIloperidonechemistry.chemical_compound0302 clinical medicineSertindoleJournal ArticlemedicineAsenapinePharmacology (medical)psychosisGeneral Pharmacology Toxicology and PharmaceuticstolerabilityPsychiatryLurasidoneBrexpiprazolePharmacologyChemical Health and Safetybusiness.industryMedicine (all)Transtornos PsicóticosGeneral Medicinepsychiatry3. Good health030227 psychiatryantipsychotics side effects tolerability safety psychosis psychiatryantipsychoticantipsychoticsside effectsPsychotic DisordersTolerabilitychemistryQuetiapineAntipsychotics; Psychiatry; Psychosis; Safety; Side effects; Tolerability; Medicine (all); Safety Research; Pharmacology Toxicology and Pharmaceutics (all); Chemical Health and Safety; Pharmacology (medical)Therapeutics. PharmacologyAntipsicóticosbusinessSafety Research030217 neurology & neurosurgeryAntipsychotic Agentsmedicine.drugTherapeutics and Clinical Risk Management
researchProduct

Early psychosis in Thauvin‐Robinet‐Faivre syndrome, a complication of the disease?

2021

Pediatricsmedicine.medical_specialtybusiness.industryEarly psychosisDiseasePhenotypePsychotic DisordersGeneticsmedicineHumansAbnormalities MultipleGenetic Predisposition to DiseaseDisease SusceptibilityAge of OnsetComplicationbusinessGenetic Association StudiesGenetics (clinical)Clinical Genetics
researchProduct

Continuity and discontinuity of affective disorders and schizophrenia. Results of a controlled family study.

1993

Background: It is widely acknowledged that the genetic diatheses for schizophrenia and affective disorders are independent. However, there are increasing doubts about this classic view, and empirical evidence for a dichotomy of these two prototypes of functional psychoses is limited. A controlled family study of consecutive admissions was conducted to determine whether familial risks for schizophrenic (SCZ) and affective disorders were independent or overlapping. Methods: Index probands met Research Diagnostic Criteria for SCZ (n=146), schizoaffective (SA [n=115]), bipolar (BP [n=80]), or unipolar major depressive (UP [n=184])disorder. Comparison probands met Research Diagnostic Criteria fo…

ProbandAdultMalemedicine.medical_specialtyBipolar DisorderPopulationResearch Diagnostic CriteriaComorbiditySex FactorsArts and Humanities (miscellaneous)Risk FactorsmedicineHistory of depressionPrevalenceHumansFamilyBipolar disordereducationPsychiatryDepression (differential diagnoses)education.field_of_studyDepressive DisorderModels GeneticAge FactorsMiddle Agedmedicine.diseaseComorbidityPsychiatry and Mental healthPhenotypePsychotic DisordersSchizophreniaSchizophreniaFemalePsychologyClinical psychologyArchives of general psychiatry
researchProduct

The risk of minor depression in families of probands with major depression: sex differences and familiality.

1992

Currently it is not clear whether minor forms of unipolar depression not matching the criteria of “major depression” should be considered as a separate diagnostic category. A controlled family study examined the familial aggregation of minor depression among probands with unipolar major depression. In the families of these probands the relative risk for minor depression was elevated by a similar magnitude to the risk for major depression. Threrefore, the diagnostic category “minor depression” would not increase diagnostic sensitivity at the expense of diagnostic specificity as far as familiality is the criterion. In agreement with recent epidemiological studies, minor depression did not rev…

ProbandAdultMalemedicine.medical_specialtyMinor (academic)Sex FactorsRisk FactorsEpidemiologymedicinePrevalenceHumansPharmacology (medical)Risk factorPsychiatryBiological PsychiatryDepression (differential diagnoses)Family HealthPsychiatric Status Rating ScalesDepressive DisorderFamily aggregationGeneral MedicinePsychiatry and Mental healthPsychotic DisordersRelative riskSchizophreniaFemalePsychologySex ratioEuropean archives of psychiatry and clinical neuroscience
researchProduct

Psychosis, symbol, affectivity 1: etiopathogenesis and treatment through analytical psychology

2021

This is the first of two papers concerning our study into an integrated approach to psychotic disorders, conducted at the University of Palermo's Psychiatry Unit Polyclinic over approximately 15 years. Here we will explore and reflect upon the acute psychotic condition mainly from a theoretical and conceptual perspective, while in the second paper we will explore the clinical perspective. From the point of view of psychopathology, and in the light of C.G. Jung's conceptualization of analytical psychology, as well as calling on contributions from other authors from the systemic-relational and post-psychoanalytic field, we will clarify the ideas developed over these last few years by our team…

PsychoanalysisJungian Theorymedia_common.quotation_subjecttreatment of psychosesPsychoanalysisPsychicJ.W. PerrySettore M-PSI/08 - Psicologia Clinicapsychotic symbolismHumansSettore MED/25 - Psichiatriamedia_commonConceptualizationPerspective (graphical)Analytical psychologyPsychodynamicsPsychotherapyClinical PsychologySymbolPolyclinicaffectivity in psychosisPsychotic Disordersanalytical psychologyPsychologyaffective neurosciencePsychopathology
researchProduct

Psychosis Is Not Illness but a Survival Strategy in Severe Stress: A Proposal for an Addition to a Phenomenological Point of View

2018

Phenomenology often looks at psychosis as a defined pathological state. In this paper, psychosis is not seen as a (pathological) state but as a way to respond in extreme stress. It is psychological functioning of the embodied and relational mind, and psychotic experience can be seen as one form of affective arousal among any other affects. Taken the point of views of Emmanuel Levinas and Mikhail Bakhtin about the primacy of living in responsive relationships, psychotic behavior is seen as emerging in relationships that do not guarantee adequate responses and thus the subject is imposed to isolate from social relationships and developing odd behavior. If dialogical responses are guaranteed, …

PsychosisDialogical selfmedicine.disease030227 psychiatryExtreme stressArousalPhenomenology (philosophy)03 medical and health sciencesPsychiatry and Mental healthClinical Psychology0302 clinical medicinePsychotic DisordersEmbodied cognitionSurvival strategySocial relationshipmedicineHumansPsychologyStress Psychological030217 neurology & neurosurgeryCognitive psychologyPsychopathology
researchProduct

The influence of risk factors on the onset and outcome of psychosis: What we learned from the GAP study

2020

The GAP multidisciplinary study carried out in South London, recruited 410 first episode of psychosis patients and 370 controls; the aim was to elucidate the multiple genetic and environmental factors influencing the onset and outcome of psychosis. The study demonstrated the risk increasing effect of adversity in childhood (especially parental loss, abuse, and bullying) on onset of psychosis especially positive symptoms. Adverse life events more proximal to onset, being from an ethnic minority, and cannabis use also played important roles; indeed, one quarter of new cases of psychosis could be attributed to use of high potency cannabis. The “jumping to conclusions” bias appeared to mediate …

PsychosisHypothalamo-Hypophyseal SystemVulnerabilityMultidisciplinary studyEthnic groupPituitary-Adrenal SystemPsychosi03 medical and health sciences0302 clinical medicineRisk FactorsLondonmedicineEthnicityHumansFirst episodeChildBiological PsychiatryMinority GroupsOutcomeFirst episodeMarkersFirst episode; Markers; Outcome; Psychosis; Schizophreniabiologybusiness.industryMarkermedicine.diseasebiology.organism_classificationPsychosis030227 psychiatryFirst episode; Markers; Outcome; Psychosis; Schizophrenia; Child; Ethnicity; Humans; London; Minority Groups; Pituitary-Adrenal System; Risk Factors; Hypothalamo-Hypophyseal System; Psychotic DisordersPsychiatry and Mental healthIncreased riskPsychotic DisordersJumping to conclusionsSchizophreniaCannabisbusiness030217 neurology & neurosurgeryClinical psychology
researchProduct